PROFUND ADVISORS LLC

Position in NKTR — Nektar Therapeutics

CIK 1129919 BETHESDA, MD

Position in NKTR

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$360,847

+$133,557 QoQ

Shares Held

5,169

+63.6% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#164

of 239 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. NKTR ranks #117 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$360,847	5,169	+63.6%	Shares	Sole	2026-08-11
2026-03-31	$227,290	3,159	-73.5%	Shares	Sole	2026-04-27
2023-03-31	$8,338	11,912	-10.1%	Shares	Sole	2023-05-12
2022-12-31	$29,933	13,245	-7.5%	Shares	Sole	2023-02-02
2022-09-30	$45,801	14,313	-61.3%	Shares	Sole	2022-11-07
2022-06-30	$140,603	37,001	-4.0%	Shares	Sole	2022-08-01
2022-03-31	$207,709	38,536	+1.1%	Shares	Sole	2022-05-10
2021-12-31	$515,068	38,125	-0.3%	Shares	Sole	2022-02-08
2021-09-30	$686,880	38,245	-7.0%	Shares	Sole	2021-11-12
2021-06-30	$705,344	41,104	-1.9%	Shares	Sole	2021-08-12
2021-03-31	$837,760	41,888	-8.4%	Shares	Sole	2021-05-14
2020-12-31	$777,325	45,725	+9.2%	Shares	Sole	2021-02-09
2020-09-30	$694,606	41,869	-9.9%	Shares	Sole	2020-11-13
2020-06-30	$1,076,129	46,465	+19.3%	Shares	Sole	2020-08-03
2020-03-31	$695,275	38,951	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.